A study has revealed that downregulation of SPAG5 suppresses the ADAM17/NOTCH1 pathway by lowering the expression of FOXM1 in malignant melanoma (MM), thereby dampening the viability, migration, invasion, and EMT of MM cells [31]. Here, ADAM17 is linked to Miyoshi myopathy.